Related Experiment Video

Updated: Oct 3, 2026

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor
09:33

Genetic Profiling and Genome-Scale Dropout Screening to Identify Therapeutic Targets in Mouse Models of Malignant Peripheral Nerve Sheath Tumor

Published on: August 25, 2023

Scoring a bull's-eye against cancer genome targets

P Workman1

  • 1CRC Centre for Cancer Therapeutics, Institute of Cancer Research, Sutton, Surrey, UK. paulw@icr.ac.uk

Current Opinion in Pharmacology
|November 17, 2001
PubMed

Insights

New anticancer drugs target specific genetic abnormalities for more effective and less toxic cancer treatment. Advances in genomic technologies are driving the development of innovative molecular therapeutics with promising clinical results.

Area of Science:

  • Oncology
  • Genomics
  • Molecular Biology

Background:

  • Current cancer treatments often involve broadly antiproliferative cytotoxic drugs.
  • Cancer progression is driven by stepwise, combinatorial genetic abnormalities.
  • Molecular and genomic technologies are revolutionizing cancer research.

Purpose of the Study:

  • To highlight the shift towards targeted anticancer therapies.
  • To discuss the impact of genomic technologies on drug discovery.
  • To showcase the clinical progress of novel molecular therapeutics.

Main Methods:

  • Review of recent advancements in anticancer drug development.
  • Analysis of the role of gene sequencing in identifying therapeutic targets.
  • Evaluation of clinical data for emerging molecular therapeutics.

Main Results:

  • Three novel anticancer agents (Herceptin, Glivec, Iressa) demonstrate significant clinical utility.
  • Genomic technologies are crucial for identifying and validating new molecular targets.
  • A new generation of genome-based molecular drugs is advancing through development.

Conclusions:

  • Targeted molecular therapeutics offer improved efficacy and reduced toxicity compared to traditional chemotherapy.
  • The integration of genomics is accelerating the development of personalized cancer treatments.
  • Continued research in molecular oncology promises further breakthroughs in cancer therapy.

More Related Videos

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization03:08

Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization

Published on: October 3, 2025

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...